GEN Exclusives

More »

GEN News Highlights

More »
Dec 6, 2013

Mary Ann Liebert Wins Stem Cell Education Award

Mary Ann Liebert Wins Stem Cell Education Award

GEN's editor in chief John Sterling introduces Mary Ann Liebert at the World Stem Cell Summit.

  • Mary Ann Liebert, president and CEO of Mary Ann Liebert Inc., and publisher of GEN, was presented with the Stem Cell Education Award by the Genetics Policy Institute. The award was given during a ceremony at dinner which took place at the World Stem Cell Summit, which is being held in San Diego this week.

    Liebert was cited for her outstanding “work in educating patients, researchers, and the broader stem cell community, and in raising the standard in medical research journalism.” Among the seventy journals the Liebert company publishes is the peer-reviewed Stem Cells and Development.

    In her acceptance speech Liebert told the audience that she was extremely gratified in being so recognized and thanked the entire staff at her company for their dedication in helping to promote excellence in medical publishing.

    In his introductory remarks during the award ceremony GEN’s long-time editor in chief John Sterling noted that Mary Ann always encourages her editors and writers “to inform, enlighten when they can, and educate as much as possible.”

    Sterling added that while she started her company 33 years ago her vision for her publications remains the same: “to help advance our knowledge of science and medicine in the best ways possible.”

    For more from the World Stem Cell Summit, be sure to check out "Neural Precursors 'Cure MS' in Mice", "$1M Award to Develop a Replacement Liver Announced", "Stem Cell Leaders Call for Human Embryome Project", and "World Stem Cell Summit: December 4, 2013 Update".

    Also, watch our video "A Brief History of Stem Cells" to see a timeline spanning over 60 years of stem cell research. 



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?